De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression
Naveen Kumar Tangudu(University of Pittsburgh), Katherine M. Aird(University of Pittsburgh)
Cited by 1
Related Papers
Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model
|Antioxidants and Redox Signaling|2017|31
Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
|Pharmaceuticals|2019|10
Suppression of p16 alleviates the senescence-associated secretory phenotype
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10
<i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression
|Cancer Research Communications|2024|9
αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation
|bioRxiv (Cold Spring Harbor Laboratory)|2024|7